122 Signatures Stand Between Massachusetts and the First Repeal of a Legal Cannabis Market
The prohibitionists' petition cleared its last threshold on July 9 by the thinnest margin in memory — and a Dorchester cannabis advocate had already filed to disqualify exactly that many names. The state's $1.65 billion adult-use market now rides on a commission ruling and a November 3 vote.
per eighth · AB 2402
Glass House Went 'Medical-Only' to Reach the NYSE — and Kept 90% of Its Stores' Profits
The $2.5 million deal that moved California's largest grower off its own dispensaries follows Trulieve's three-week-old playbook. But Kyle Kazan's real target isn't the opening bell — it's the export and interstate-commerce market that rescheduling just cracked open.
per eighth · AB 2402
Weedmaps Was Worth $1.5 Billion. It Just Quit Nasdaq Worth $45 Million.
Justin Hartfield's gray-market dispensary directory grew into the SPAC era's cannabis darling — then the 'cannabis winter' and a regulatory reckoning gutted it. On April 24, a smaller, profitable WM Technology delisted to the OTC markets, with its CEO calling the retreat a path to victory.
Legal to Grow, Illegal to Buy: Spanberger's Veto Keeps Virginia's $780M Market Dark
Abigail Spanberger campaigned on a promise to sign adult-use legislation. On May 19 she vetoed it instead — siding against sponsors in her own party and pushing legal sales to 2027 at the earliest, leaving five medical operators holding the only legal storefronts and equity applicants back in limbo.
Three Republican AGs Sued Trump's DOJ to Undo Rescheduling. Operators' 280E Relief Is the Collateral.
Indiana, Nebraska, and Louisiana filed a 15-page petition in the D.C. Circuit on May 22 to vacate the Schedule III order their own party's Justice Department signed in April. If they win, the tax relief that just turned medical operators profitable disappears — and the June 29 DEA hearing happens under a cloud.